Rare diseases
Investigational molecules
Locations
Study on Glenzocimab for Patients with Large Ischemic Stroke Eligible for Endovascular Therapy
FranceStudy on PET Tracers [18F]F-AraG and [89Zr]Zr-Df-Crefmirlimab for Evaluating T Cell Activation in Non-Small Cell Lung Cancer Patients
The NetherlandsStudy on the Effects of Psilocybin for Patients with Psychogenic Non-Epileptic Seizures (PNES)
FranceStudy on the Safety and Effectiveness of Human Alpha1-Proteinase Inhibitor for Preventing Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplant.
GermanyStudy on the Effectiveness and Safety of RO7198457 and Pembrolizumab for Patients with Untreated Advanced Melanoma
GermanyStudy of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
CzechiaStudy comparing darolutamide versus hormone therapy (goserelin, leuprorelin, triptorelin, degarelix) in men with untreated hormone-sensitive prostate cancer
BelgiumStudy of Gilteritinib and Chemotherapy for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation
FranceStudy of Trastuzumab Deruxtecan for Patients with HER2-Low Breast Cancer and New or Worsening Brain Metastases
AustriaStudy of Selpercatinib for Patients with Early-Stage RET Fusion-Positive Non-Small Cell Lung Cancer After Local Treatment
AustriaStudy of mRNA-4157 and Pembrolizumab for Patients with Resectable Locally Advanced Cutaneous Squamous Cell Carcinoma
BelgiumStudy on RL-007 for Improving Cognitive Impairment in Schizophrenia Patients
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
